CAPRICOR THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Capricor Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Capricor Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$12.6M, a 96.5% decline year-over-year.
  • Capricor Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$34.1M, a 16.6% decline year-over-year.
  • Capricor Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$22.3M, a 23.2% increase from 2022.
  • Capricor Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$29M, a 44.9% decline from 2021.
  • Capricor Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$20M, a 46.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$34.1M -$12.6M -$6.17M -96.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$27.9M -$11M -$3.63M -49.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$24.3M -$9.79M -$2.03M -26.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$22.3M -$762K +$6.96M +90.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$29.2M -$6.39M -$19.5K -0.31% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$29.2M -$7.37M -$257K -3.62% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$29M -$7.77M +$49.8K +0.64% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$29M -$7.72M -$1.53M -24.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$27.5M -$6.37M -$2.44M -62% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$25M -$7.11M -$2.36M -49.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$22.7M -$7.82M -$2.67M -51.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$20M -$6.19M -$2.01M -48.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-17
Q3 2021 -$18M -$3.93M -$21.7K -0.56% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$18M -$4.75M -$1.26M -36.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$16.7M -$5.15M -$3.07M -147% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$13.7M -$4.18M -$2.71M -184% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$10.9M -$3.91M -$2.3M -143% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$8.64M -$3.48M -$1.44M -70.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$7.21M -$2.08M +$435K +17.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$7.64M -$1.47M +$1.79M +54.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$9.43M -$1.61M +$2.53M +61.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$12M -$2.05M +$2.08M +50.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-13
Q1 2019 -$14M -$2.52M +$1.15M +31.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-13
Q4 2018 -$15.2M -$3.26M -$15.6M -126% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $374K -$4.14M -$1.4M -51.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $1.78M -$4.12M -$651K -18.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-08
Q1 2018 $2.43M -$3.67M -$4.91K -0.13% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-08
Q4 2017 $2.43M $12.3M +$16.8M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$14.4M -$2.73M +$2.6M +48.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$17M -$3.47M +$1.22M +25.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$18.2M -$3.67M +$600K +14.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$18.8M -$4.52M -$1.17M -35% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-22
Q3 2016 -$17.6M -$5.33M -$2.42M -83.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$15.2M -$4.69M -$1.57M -50.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$13.6M -$4.27M -$790K -22.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$12.9M -$3.35M -$1.42M -73.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$11.4M -$2.91M -$1.37M -88.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$10.1M -$3.12M -$1.59M -104% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$8.48M -$3.48M -$2.27M -187% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$6.22M -$1.93M +$2.38M +55.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$8.59M -$1.54M +$1.25K +0.08% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$8.59M -$1.53M +$90.7K +5.58% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$8.69M -$1.21M +$207K +14.6% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$8.89M -$4.3M -$3.92M -1032% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$4.97M -$1.55M -$979K -173% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$3.99M -$1.62M -$1.27M -360% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$2.72M -$1.42M -$645K -83.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$2.07M -$380K -$2.45M -118% Oct 1, 2012 Dec 31, 2012 10-Q 2014-05-15
Q3 2012 $380K -$566K +$578K +50.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$198K -$353K +$528K +59.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$725K -$772K +$424K +35.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-06-21
Q4 2011 -$1.15M $2.07M Oct 1, 2011 Dec 31, 2011 10-Q 2014-05-15
Q3 2011 -$1.14M +$665K +36.8% Jul 1, 2011 Sep 30, 2011 10-Q 2013-06-21
Q2 2011 -$881K +$614K +41.1% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-10
Q1 2011 -$1.2M Jan 1, 2011 Mar 31, 2011 10-Q/A 2012-05-15
Q3 2010 -$1.81M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.49M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.